Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

April 1997

Making $1 Billion Disappear

MOST PEOPLE WOULD AGREE WITH ME THAT $1 BILLION IS A HUGE AMOUNT of money. It generally takes the federal government to squander amounts that big. The Internal Revenue Service’s $2 billion computer boondoggle is the latest example of government incompetence with taxpayers’ money. So I feel I will be in good company when I express …

Making $1 Billion Disappear Read More »

To access this post, you must purchase The Dark Report.

AmeriPath Stock Offering Pulled By Underwriters

CEO SUMMARY: Ameripath planned to go public in March. However, the stock market’s significant decline and further evaluation of the company’s business plan caused Wall Street underwriters to defer issuing the stock. Pathologists are curious as to whether AmeriPath’s “employee” business model influenced decisions about the public stock offering. UNDERWRITERS on Wall Street decided to …

AmeriPath Stock Offering Pulled By Underwriters Read More »

To access this post, you must purchase The Dark Report.

Success Seems Elusive To Pathology Innovators

CEO SUMMARY: Attempts to organize pathology practice management companies encounter resistance and market impediments. Success requires an astute business plan and a sophisticated management team to convince pathologists to abandon proven practice models and affiliate with regional or national pathology companies. PATHOLOGISTS ARE NOTORIOUS for their skepticism and resistance to change. However, during the last …

Success Seems Elusive To Pathology Innovators Read More »

To access this post, you must purchase The Dark Report.

Where’s The Write-down ? LabCorp Faces Key Decision

CEO SUMMARY: Commercial laboratories are recognizing declines in the market value of their assets. LabCorp has yet to do the same. Taken cumulatively, these write-downs demonstrate the sizable revenue erosion that large commercial laboratories experienced during the past three years. Soon it will be LabCorp’s turn to address this issue. MORE THAN $550 MILLION of …

Where’s The Write-down ? LabCorp Faces Key Decision Read More »

To access this post, you must purchase The Dark Report.

LabCorp Struggling To Regain Financial, Operational Balance

CEO SUMMARY: 1997 will be a “make or break” year for Laboratory Corporation of America. The company is challenged on many fronts. As LabCorp’s management focuses on internal issues, nimble laboratory competitors have an opportunity to capture additional market share. STABILITY CONTINUES to elude Laboratory Corporation of America. Wracked by a variety of setbacks over …

LabCorp Struggling To Regain Financial, Operational Balance Read More »

To access this post, you must purchase The Dark Report.

Laboratory War College To Highlight Innovation

CEO SUMMARY: Quickly establishing itself as the premiere event for the management of clinical laboratories, this year’s Executive War College in New Orleans offers specialized advice and experience for laboratory administrators. Expect to hear the first public presentations about innovative discoveries which lower costs and boost laboratory performance. SPECIAL PRESENTATIONS scheduled for this year’s EXECUTIVE …

Laboratory War College To Highlight Innovation Read More »

To access this post, you must purchase The Dark Report.

“April 21, 1997 Intelligence: Late Breaking Lab News”

Quest Diagnostics Incorporated reported quarterly earnings last week. It is the first look at the financial performance of the newly-independent spin off from Corning Incorporated. The company reported net income of $4.0 million on revenues of $388.1 million. Revenues declined 3.3% from same quarter last year. This indicates that revenue erosion still continues. MORE ON: …

“April 21, 1997 Intelligence: Late Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.

;